Improved Quality of Life, Fitness, Mental Health and Cardiovascular Risk Factors with a Publicly Funded Bariatric Lifestyle Intervention for Adults with Severe Obesity: A Prospective Cohort Study.
Adult
Anxiety
/ epidemiology
Bariatrics
/ methods
Body Mass Index
Cardiovascular Diseases
/ epidemiology
Cholesterol, LDL
/ blood
Cohort Studies
Depression
/ epidemiology
Exercise
Female
Glycated Hemoglobin
/ analysis
Heart Disease Risk Factors
Humans
Life Style
Male
Mental Health
Middle Aged
Obesity
/ psychology
Prospective Studies
Quality of Life
Surveys and Questionnaires
anxiety
bariatric
depression
diet
fitness
physical activity
quality of life
severe obesity
structured lifestyle modification
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
21 Nov 2021
21 Nov 2021
Historique:
received:
21
10
2021
revised:
15
11
2021
accepted:
19
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Lifestyle modification is the cornerstone of management for patients with severe and complicated obesity, but the effects of structured lifestyle programmes on quality of life, anxiety and depression scores and cardiovascular risk factors are not well-described. We sought to describe changes in self-reported quality of life and mental health-related outcomes as well as cardiovascular risk factors in patients completing a 10-week multidisciplinary lifestyle-modification programme. We conducted a prospective cohort study of all patients referred from our bariatric service who completed the programme between 2013 and 2019. In addition to weight, body mass index (BMI), blood pressure, HbA1c, lipid profile and functional capacity, we quantified health-related quality of life using the Dartmouth COOP Questionnaire and the European Quality of Life Questionnaire Visual Analogue Scale (EQVAS) and mental health using the Hospital Anxiety and Depression Scale (HADS). Of 1122 patients who started the programme, 877 (78.2%) completed it and were included in per protocol analyses. Mean age was 47.3 ± 11.9 years, 66.9% were female, 34.8% were in full- or part-time employment and 69.4% were entitled to state-provided medical care. BMI decreased from 47.0 ± 7.8 to 46.2 ± 7.8 kg m Adults with severe and complicated obesity completing a specialised bariatric lifestyle-modification programme showed significant improvements in self-reported mental health and quality of life, in addition to reductions in cardiovascular risk factors.
Sections du résumé
BACKGROUND
BACKGROUND
Lifestyle modification is the cornerstone of management for patients with severe and complicated obesity, but the effects of structured lifestyle programmes on quality of life, anxiety and depression scores and cardiovascular risk factors are not well-described. We sought to describe changes in self-reported quality of life and mental health-related outcomes as well as cardiovascular risk factors in patients completing a 10-week multidisciplinary lifestyle-modification programme.
METHODS
METHODS
We conducted a prospective cohort study of all patients referred from our bariatric service who completed the programme between 2013 and 2019. In addition to weight, body mass index (BMI), blood pressure, HbA1c, lipid profile and functional capacity, we quantified health-related quality of life using the Dartmouth COOP Questionnaire and the European Quality of Life Questionnaire Visual Analogue Scale (EQVAS) and mental health using the Hospital Anxiety and Depression Scale (HADS).
RESULTS
RESULTS
Of 1122 patients who started the programme, 877 (78.2%) completed it and were included in per protocol analyses. Mean age was 47.3 ± 11.9 years, 66.9% were female, 34.8% were in full- or part-time employment and 69.4% were entitled to state-provided medical care. BMI decreased from 47.0 ± 7.8 to 46.2 ± 7.8 kg m
CONCLUSIONS
CONCLUSIONS
Adults with severe and complicated obesity completing a specialised bariatric lifestyle-modification programme showed significant improvements in self-reported mental health and quality of life, in addition to reductions in cardiovascular risk factors.
Identifiants
pubmed: 34836428
pii: nu13114172
doi: 10.3390/nu13114172
pmc: PMC8618364
pii:
doi:
Substances chimiques
Cholesterol, LDL
0
Glycated Hemoglobin A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Eur Heart J. 2012 Jul;33(13):1635-701
pubmed: 22555213
Ann Med. 2014 Aug;46(5):273-82
pubmed: 24491067
BMJ. 2014 Nov 27;349:g6608
pubmed: 25430558
Lancet. 2006 Nov 11;368(9548):1673-9
pubmed: 17098085
Obesity (Silver Spring). 2011 Nov;19(11):2274-9
pubmed: 21566566
BMC Endocr Disord. 2019 Jul 1;19(1):69
pubmed: 31262301
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2985-3023
pubmed: 24239920
Lancet. 2008 May 24;371(9626):1783-9
pubmed: 18502303
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889
Health Econ. 2017 Aug;26(8):1052-1066
pubmed: 27515829
Cochrane Database Syst Rev. 2014 Aug 08;(8):CD003641
pubmed: 25105982
Int J Obes (Lond). 2010 Mar;34(3):407-19
pubmed: 19997072
Clin Obes. 2016 Dec;6(6):395-403
pubmed: 27788558
Front Nutr. 2020 Sep 30;7:551068
pubmed: 33117840
N Engl J Med. 2019 Dec 19;381(25):2440-2450
pubmed: 31851800
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Thorax. 1992 Dec;47(12):1019-24
pubmed: 1494764
Obes Rev. 2018 Dec;19(12):1679-1687
pubmed: 30155959
Arch Intern Med. 2010 Jan 25;170(2):146-54
pubmed: 20101009
JAMA. 1999 Oct 27;282(16):1547-53
pubmed: 10546694
Diabetes Metab Syndr Obes. 2020 Jan 23;13:197-205
pubmed: 32158243
J Psychosom Res. 2009 Apr;66(4):277-85
pubmed: 19302884
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
JAMA. 2018 Sep 18;320(11):1172-1191
pubmed: 30326501
Eur J Prev Cardiol. 2014 Mar;21(3):366-76
pubmed: 23884981
J Am Coll Nutr. 2017 Mar-Apr;36(3):223-233
pubmed: 28394727
J Public Health (Oxf). 2005 Jun;27(2):156-64
pubmed: 15820993
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
JAMA. 2003 Apr 9;289(14):1813-9
pubmed: 12684360
Diabetes Metab Res Rev. 2021 Nov;37(8):e3458
pubmed: 33891377
N Engl J Med. 2007 Aug 23;357(8):741-52
pubmed: 17715408
BMJ Open. 2019 Sep 11;9(9):e029473
pubmed: 31511284
JAMA. 2018 Sep 18;320(11):1163-1171
pubmed: 30326502
Clin Obes. 2013 Feb;3(1-2):39-50
pubmed: 25586390
PLoS One. 2013 Nov 13;8(11):e79827
pubmed: 24236162
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Behav Cogn Psychother. 2009 Mar;37(2):129-40
pubmed: 19364414
Diabetes Care. 2014 Jun;37(6):1544-53
pubmed: 24855155
J Acad Nutr Diet. 2014 Oct;114(10):1557-68
pubmed: 25257365
N Engl J Med. 2013 Jul 11;369(2):145-54
pubmed: 23796131
Ann Intern Med. 2005 Nov 1;143(9):659-72
pubmed: 16263889
BMC Endocr Disord. 2015 Aug 01;15:37
pubmed: 26231181
Lancet. 2008 Jun 14;371(9629):1999-2012
pubmed: 18555911
Diabetologia. 2018 Dec;61(12):2461-2498
pubmed: 30288571
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Am J Health Promot. 2021 Jan;35(1):68-76
pubmed: 32545994
J Am Diet Assoc. 2007 Oct;107(10):1755-67
pubmed: 17904936
Circulation. 2016 Dec 13;134(24):e653-e699
pubmed: 27881567
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
Obes Rev. 2020 Jun;21(6):e12998
pubmed: 31994311
Int J Obes (Lond). 2011 Nov;35(11):1363-76
pubmed: 21343903
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
BMJ Open. 2015 Mar 16;5(3):e006189
pubmed: 25776042
N Engl J Med. 2012 Apr 26;366(17):1567-76
pubmed: 22449319
Psychosom Med. 2008 Apr;70(3):288-97
pubmed: 18378873
Fam Pract. 1999 Apr;16(2):190-5
pubmed: 10381028
Surg Obes Relat Dis. 2017 Jun;13(6):1052-1056
pubmed: 28256395
Obes Facts. 2014;7(2):96-101
pubmed: 24685592